SCSijing Chen

Sijing Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sijing Chen has a total of 103 co-authors. Here are the top co-authors by number of shared publications:

  • Hans Ivers

    École de psychologie, Université Laval, Québec, Québec, Canada; Centre d'étude des troubles du sommeil, Université Laval, Québec, Québec, Canada

    4 shared publications
  • Ngan Yin Chan

    Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine The Chinese University of Hong Kong Hong Kong SAR China

    3 shared publications
  • Charles M. Morin

    École de psychologie, Université Laval, Québec, Québec, Canada; Centre d'étude des troubles du sommeil, Université Laval, Québec, Québec, Canada

    2 shared publications
  • Charles M. Morin

    Université Laval

    2 shared publications
  • Jihui Zhang

    Key Laboratory of Sleep and Biological Rhythms of Guangdong Province, Center for Sleep and Circadian Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China

    2 shared publications
  • Judith R. Davidson

    Department of Psychology, Queen's University, Kingston, Ontario, Canada

    2 shared publications

Latest Publications

  • Fecal microbiota transplantation‐based treatment protocol for chronic insomnia disorder: A randomized, double‐blind, placebo‐controlled trial

    by Teng Gao, Xiaoxing Liu, Weifeng Mi, Le Shi, Xueqin Wang, Daomin Zhu, Feng Geng, Yixiao Fu, Yongfeng Yang, Xinrong Li, et al.

    Objective: Chronic insomnia disorder is common and burdensome, and current treatments remain limited. We conducted a multicenter, randomized, double‐blind, placebo‐controlled trial to determine whether a fecal microbiota transplantation (FMT)‐based treatment protocol improves sleep outcomes in adults with chronic insomnia disorder. Methods: Participants were randomly assigned 1:1 to receive short‐course antibiotic pretreatment followed by donor microbiota capsules ( n = 40) or placebo capsules without antibiotic pretreatment ( n = 40). Within each group, participants were further randomized to receive synbiotic supplementation or matched placebo for prespecified exploratory subgroup analyses. The primary outcome was polysomnography‐measured sleep efficiency (SE) at 1 month after treatment. Secondary outcomes included other polysomnographic parameters, patient‐reported sleep outcomes, and safety; microbiota analyses were exploratory. Results: Compared with placebo, the FMT‐based treatment protocol improved SE (adjusted between‐group difference, 13.9 percentage points; 95% CI 7.29–20.41; p = 0.003) and reduced wake after sleep onset. Synbiotic assignment did not suggest meaningful differences in SE. Insomnia Severity Index and Pittsburgh Sleep Quality Index scores showed sustained improvement from 2 to 6 months. Treatment was well tolerated, with mild, self‐limited adverse events and no serious adverse events. The intervention increased microbial richness and diversity and altered community structure; responders and non‐responders showed similar posttreatment β ‐diversity change but differed in baseline microbiota composition. Conclusion: In adults with chronic insomnia disorder, an FMT‐based treatment protocol incorporating antibiotic pretreatment improved objective sleep continuity and sustained subjective insomnia outcomes. Baseline microbial composition may contribute to treatment heterogeneity and merits further investigation.

  • Current Evidence on Sleep and Women’s Mental Health

    by Xinchen Ye, Yun Kwok Wing, Sijing Chen, Ngan Yin Chan

  • Open Access

    The complex association between bedtime screen use and adult sleep health

    by Lydi-Anne Vézina-Im, Charles M. Morin, Sijing Chen, Hans Ivers, Colleen E. Carney, Jean-Philippe Chaput, Thien Thanh Dang-Vu, Judith R. Davidson, Rébecca Robillard


  • Open Access

    Stepped care for insomnia in primary care using digital and face-to-face cognitive behavioral therapies: A pragmatic nonrandomized clinical trial

    by Charles M. Morin, Si-Jing Chen, Kathleen Lemieux, Hans Ivers, Janet M.Y. Cheung, Manon Lamy, Lee Ritterband


  • Top Cited Papers
    Open Access

    Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial

    by Si-Jing Chen, Jian-Yu Que, Ngan Yin Chan, Le Shi, Shirley Xin Li, Joey Wing Yan Chan, Weizhen Huang, Chris Xie Chen, Chi Ching Tsang, Yuen Lam Ho, et al.

    Background: Increasing evidence suggests that insomnia plays an important role in the development of depression, supporting insomnia intervention as a promising approach to prevent depression in youth. This randomized controlled trial evaluated the effectiveness of app-based cognitive behavioral therapy for insomnia (CBT-I) in preventing future onset of major depressive disorder (MDD) in youth. Methods and findings: This was a randomized, assessor-blind, parallel group-controlled trial in Chinese youth (aged 15−25 years) with insomnia disorder and subclinical depressive symptoms. Participants were randomly assigned (1:1) to 6-week app-based CBT-I or 6-week app-based health education (HE) delivered through smartphones. Online assessments and telephone clinical interviews were conducted at baseline, post-intervention, 6- and 12-month follow-ups. The primary outcome was time to onset of MDD. The secondary outcomes included depressive symptoms and insomnia at both symptom and disorder levels. Between September 9, 2019, and November 25, 2022, 708 participants (407 females [57%]; mean age, 22.1 years [SD = 1.9]) were randomly allocated to app-based CBT-I group (n = 354) or app-based HE group (n = 354). Thirty-seven participants (10%) in the intervention group and 62 participants (18%) in the control group developed new-onset MDD throughout the 12-month follow-up, with a hazard ratio of 0.58 (95% confidence interval 0.38–0.87; p = 0.008). The number needed to treat to prevent MDD at 1 year was 10.9 (6.8–26.6). The app-based CBT-I group has higher remission rates of insomnia disorder than the controls at post-intervention (52% versus 28%; relative risk 1.83 [1.49–2.24]; p < 0.001) and throughout 12-month follow-up. In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference −1.0 [−1.6 to −0.5]; Cohen’s d = 0.53; p < 0.001) and insomnia symptoms (−2.0 [−2.7 to −1.3], d = 0.78; p < 0.001) than the controls at post-intervention and throughout 6-month follow-up. Insomnia was a mediator of intervention effects on depression. No adverse events related to the interventions were reported. Conclusions: App-based CBT-I is effective in preventing future onset of major depression and improving insomnia outcomes among youth with insomnia and subclinical depression. These findings highlight the importance of targeting insomnia to prevent the onset of MDD and emphasize the need for wider dissemination of digital CBT-I to promote sleep and mental health in the youth population. Trial registration: ClinicalTrials.Gov (NCT04069247).


  • Open Access

    Prevalence of insomnia and use of sleep aids among adults in Canada

    by Charles M. Morin, Lydi-Anne Vézina-Im, Si-Jing Chen, Hans Ivers, Colleen E. Carney, Jean-Philippe Chaput, Thien Thanh Dang-Vu, Judith R. Davidson, Geneviève Belleville, Dominique Lorrain, et al.


  • Open Access

    School-Based Sleep Education Program for Children: A Cluster Randomized Controlled Trial

    by Si-Jing Chen, Shirley Xin Li, Ji-Hui Zhang, Siu Ping Lam, Mandy Wai Man Yu, Chi Ching Tsang, Alice Pik Shan Kong, Kate Ching Ching Chan, Albert Martin Li, Yun Kwok Wing, et al.

    Insufficient sleep contributes negatively to child developmental processes and neurocognitive abilities, which argues the need for implementing interventions to promote sleep health in children. In this study, we evaluated the effectiveness of a multimodal and multilevel school-based sleep education program in primary school children using a cluster randomized controlled design. Twelve schools were randomly assigned to either the sleep education or nonactive control groups. The sleep education group included a town hall seminar, small class teaching, leaflets, brochures, and a painting competition for children. Parents and teachers were invited to participate in a one-off sleep health workshop. Parental/caregiver-reported questionnaires were collected at baseline and 1-month follow-up. A total of 3769 children were included in the final analysis. There were no significant improvements observed in the sleep-wake patterns, daytime functioning, and insomnia symptoms between the two groups at follow-up, whereas the intervention group had significantly improved parental sleep knowledge than the controls (paternal: adjusted mean difference: 0.95 [95% confidence interval (CI): 0.18 to 1.71]; maternal: adjusted mean difference: 0.87 [95% CI: 0.17 to 1.57]). In addition, children receiving the intervention had a lower persistence rate of excessive beverage intake (adjusted odds ratio: 0.49 [95% CI: 0.33 to 0.73]), and experienced greater reductions in conduct problems (adjusted mean difference: 0.12 [95% CI: 0.01 to 0.24]) compared with the controls at 1-month of follow-up. Moreover, a marginally significant reduction for emotional problems in the intervention group was also observed (adjusted mean difference: 0.16 [95% CI: −0.00 to 0.32]). These findings demonstrated that school-based sleep education was effective in enhancing parental sleep knowledge and improving behavioral outcomes in children, but not sufficient in altering the children’s sleep-wake patterns and sleep problems.


  • Open Access

    Profile of gut microbiota in patients with traumatic thoracic spinal cord injury and its clinical implications: a case-control study in a rehabilitation setting

    by Binbin Yu, Huaide Qiu, Shupeng Cheng, Feng Ye, Jiahui Li, Sijing Chen, Li Zhou, Yumei Yang, Caiyun Zhong, Jianan Li

    Gut microbiota are the candidate biomarkers for neurogenic bowel dysfunction (NBD) in patients with spinal cord injury (SCI). We aimed to identify the common features between patients with varying degree of thoracic SCI and healthy individuals and subpopulations of microbiota correlated with the serum biomarkers. Twenty-one patients with complete thoracic SCI (CTSCI), 24 with incomplete thoracic SCI (ITSCI), and 24 healthy individuals (HC) were enrolled in this study. Fresh stool samples and clinical data were collected from all participants, and their bowel functions with SCI were assessed. Microbial diversity and composition were analyzed by sequencing the 16S rRNA gene. The features of gut microbiota correlated with the serum biomarkers and their functions were investigated. The mean NBD score of patients with CTSCI was higher than that of patients with ITSCI. Diversity of the gut microbiota in SCI group was reduced, and with an increase in the degree of damage, alpha diversity had decreased gradually. The composition of gut microbiota in patients with SCI was distinct from that in healthy individuals, and CTSCI group exhibited further deviation than ITSCI group compared to healthy individuals. Four serum biomarkers were found to be correlated with most differential genera. Patients with thoracic SCI present gut dysbiosis, which is more pronounced in patients with CTSCI than in those with ITSCI. Therefore, the gut microbiota profile may serve as the signatures for bowel and motor functions in patients with thoracic SCI. GRAPHICAL ABSTRACT


  • Super plasticity in a cold-welded Al-Cu joint

    by Jing Gao, Kaifeng Wang, Xiaoqian Fu, Sijing Chen, Zijiao Zhang, Qiannan Wang, Jingjing Li, Qian Yu

    The technology of welding dissimilar metals at the nanoscale is of importance in the fabrication of electronics. In this work, we achieved cold welding of aluminum (Al) and copper (Cu) nanowires by simple mechanical contact without extra heating and/or voltage applied in transmission electron microscopy (TEM). During the welding process, the welding surface gradually disappeared due to the significant inter-diffusion between Al and Cu under a relatively low pressure, which resulted in the formation of an Al/Cu solid solution and Al3Cu2 intermetallic compound. The following in-situ TEM tensile test revealed that the joint displayed super plasticity with a total elongation even beyond 100%. The corresponding plastic deformation was dominated by the partial dislocation glide and grain rotation. Our results not only shed light on developing the advanced welding technology for dissimilar metals at the nanoscale but also improved the understanding of the joint deformation mechanisms.